June 2012
Monthly Prescribing Reference;Jun2012, Vol. 28 Issue 6, pA-27
The article presents information on key elements available in every pharmaceutical product monograph in the U.S.. It mentions that a brand name is provided under which the product and other dosage forms in the monograph are marketed. It informs that the pharmacology of the drug is also listed in italics. It reveals that drug formulations also appear on the monograph. Also highlights drugs approved indications, warnings, and interactions.


Related Articles

  • Solid dosage forms from self-emulsifying lipidic formulations. Marchaud, Deiphine; Hughes, Sophie // Pharmaceutical Technology Europe;Apr2008, Vol. 20 Issue 4, p46 

    The article provides information on the growing interest in the use of self-emulsifying lipid formulations (SELFs) due to their ability to solubilize poorly water-soluble lipophilic drugs and overcome the problem of poor drug absorption. The author stated that the formulations can improve the...

  • A Lifecyde Approach to Process Validation. Milmo, Sean // BioPharm International;Jun2013, Vol. 26 Issue 6, p14 

    The article offers information on a lifecycle system which is a science and risk based approach that aims to verify operating process of manufacturing a drug within predefined specified parameters. It informs that the European Medicines Agency (EMA) implements this system for verification of new...

  • Congress Considers Legislation to Secure Drug Supply Chain. Wechsler, Jill // BioPharm International;Jun2013, Vol. 26 Issue 6, p10 

    The article offers information on several legislative bills introduced by the leader of the Senate Health, Education, Labor & Pensions Committee and the House Energy and Commerce (E&C) for regulating drug compounding. It informs about a Senate bill created by Senate leader which differentiate...

  • Current FDA-Related Drug Information. Baker, Danial E. // Hospital Pharmacy;Jan2009, Vol. 44 Issue 1, p69 

    Several tables that provide information on approved drugs, dosage forms and labeling changes in the U.S. are presented.

  • Cypress Pharmaceutical Inc.  // Chain Drug Review;9/28/2009, Vol. 31 Issue 16, p84 

    The article presents a corporate profile of generic pharmaceutical company Cypress Pharmaceutical Inc. in the U.S. The company, founded in 1933, markets and distributes more than 125 generic drugs in a group of therapeutic categories and dosage forms. Greg Stofko, the company's vice president of...

  • SOLID DOSAGE Manufacturing Trends. Wright, Tim // Contract Pharma;Mar2015, Vol. 17 Issue 2, pS-4 

    The article discusses the trends in oral solid dosage form in the biopharmaceutical contract manufacturing industry in the U.S. Cited key drivers in the evolving manufacture of solid dosage forms include functional improvements, safety and overall cost of development and commercial manufacture....

  • Regulatory morass. Zigmond, Jessica // Modern Healthcare;11/19/2012, Vol. 42 Issue 47, p7 

    The article discusses the highlights of congressional hearings concerning the nationwide fungal meningitis outbreak. The outbreak is linked to contaminated, compound methylprednisolone acetate, an injectable steroid distributed by New England Compounding Center. U.S. Food and Drug Administration...

  • INTERPHEX 2014: New Partners, New Programs. Palermo, R. J. // Pharmaceutical Technology;Mar2014, Vol. 38 Issue 3, p12 

    The article offers information on the International Pharmaceutical Exposition 2014 (INTERPHEX) to be held on March 21 to 23, 2014 at Javits Center in New York City and its educational sessions that support all dosage forms including the Specialty Forum on March 19, 2014.

  • Manufacturer takes issue with 17P article. GUDEMAN, JENNIFER; JOZWIAKOWSKI, MICHAEL; CHOLLET, JOHN; CABALEIRO, JOE // Contemporary OB/GYN;May2012, Vol. 57 Issue 5, p10 

    A letter to the editor is presented in response to the article "17P: Choosing a quality compounding pharmacy," by Joe Cabaleiro in the March 1, 2012 issue.


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics